Ken Stern & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Ken Stern & Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$349K	Hold	2,862	–	–	0.15%	87
2018 Q2	$314K	Hold	2,862	–	–	0.14%	91
2018 Q1	$305K	Sell	2,862 -258	-8%	-$28.6K	0.13%	88
2017 Q4	$333K	Sell	3,120 -30	-1%	-$3.21K	0.15%	83
2017 Q3	$350K	Sell	3,150 -51	-2%	-$5.45K	0.15%	72
2017 Q2	$330K	Hold	3,201	–	–	0.15%	75
2017 Q1	$318K	Sell	3,201 -132	-4%	-$12.6K	0.15%	80
2016 Q4	$295K	Sell	3,333 -192	-5%	-$17.5K	0.15%	90
2016 Q3	$340K	Buy	+3,525	New	+$335K	0.23%	60

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ken Stern & Associates's IBB Position: Q3 2018 in Review

Ken Stern & Associates held its iShares Biotechnology ETF (IBB) position steady in Q3 2018 at 2,862 shares worth $349K. The position accounts for 0.15% of the portfolio, ranked #87.

Ken Stern & Associates first reported a position in IBB in Q3 2016 and has held it in 9 quarters since. The position peaked at $350K in Q3 2017. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

Ken Stern & Associates held 2,862 shares of iShares Biotechnology ETF worth $349K as of Q3 2018.
Ken Stern & Associates left its iShares Biotechnology ETF share count unchanged in Q3 2018.
iShares Biotechnology ETF made up 0.15% of Ken Stern & Associates's portfolio in Q3 2018, its #87 holding.
Ken Stern & Associates first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 9 quarters since.
Ken Stern & Associates's iShares Biotechnology ETF position peaked at $350K in Q3 2017.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.